Cochran Christopher P. 4
4 · Coeptis Therapeutics Holdings, Inc. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Cochran Christopher P.
Director
Transactions
- Award
Non-qualified Stock Options (right to buy)
2023-01-27+30,000→ 30,000 totalExercise: $1.60→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan.
- [F2]The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.
- [F3]Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 4/27/2023, the next 25% vesting on 7/27/2023, the next 25% vesting on 10/27/23, and the final 25% vesting on 1/27/24.
- [F4]Expiration date is ten years from the day of grant.